Optic Neuritis (Ophthalmology) Drugs Pipeline Guide 2021 – ResearchAndMarkets.com |

Optic Neuritis (Ophthalmology) Drugs Pipeline Guide 2021 – ResearchAndMarkets.com |



The “Optic Neuritis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com‘s offering.

This report provides comprehensive information on the therapeutics under development for Optic Neuritis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Optic Neuritis pipeline guide also reviews of key players involved in therapeutic development for Optic Neuritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 1, 3 and 5 respectively. Similarly, the Universities portfolio in Phase II and Discovery stages comprises 1 and 1 molecules, respectively.

The guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Repot Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Optic Neuritis (Ophthalmology).
  • The pipeline guide reviews pipeline therapeutics for Optic Neuritis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Optic Neuritis (Ophthalmology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Optic Neuritis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews the latest news related to pipeline therapeutics for Optic Neuritis (Ophthalmology)

Companies Mentioned

  • Accure Therapeutics SL
  • EnhanX Biopharm Inc
  • Japan Innovative Therapeutics Inc
  • Meta-IQ ApS
  • Mitochon Pharmaceuticals Inc
  • Noveome Biotherapeutics Inc
  • ReNetX Bio
  • SanBio Co Ltd


Key Topics Covered:


Optic Neuritis – Overview

Optic Neuritis – Therapeutics Development

  • Pipeline Overview
  • Pipeline by Companies
  • Pipeline by Universities/Institutes
  • Products under Development by Companies
  • Products under Development by Universities/Institutes

Optic Neuritis – Therapeutics Assessment

  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Administration
  • Assessment by Molecule Type

Optic Neuritis – Companies Involved in Therapeutics Development

  • Accure Therapeutics SL
  • EnhanX Biopharm Inc
  • Japan Innovative Therapeutics Inc
  • Meta-IQ ApS
  • Mitochon Pharmaceuticals Inc
  • Noveome Biotherapeutics Inc
  • ReNetX Bio
  • SanBio Co Ltd

Optic Neuritis – Drug Profiles

Optic Neuritis – Dormant Projects

Optic Neuritis – Discontinued Products

Optic Neuritis – Product Development Milestones

Featured News & Press Releases

For more information about this report visit https://www.researchandmarkets.com/r/am4dlh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210917005231/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 09/17/2021 07:20 AM/DISC: 09/17/2021 07:21 AM


Copyright Business Wire 2021.


Source link

Robert Swift

Leave a Reply

Your email address will not be published. Required fields are marked *